Data analyses back Sanofi dengue vaccine: study
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
Jul 28, 2015
0
40
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
Jul 28, 2015
0
40
Researchers at the University of Oxford have today published in Preprints with The Lancet an analysis of further data from the ongoing trials of the vaccine. In this, they reveal that the vaccine efficacy is higher at longer ...
Feb 3, 2021
0
92
Moderna said Thursday its COVID-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.
May 6, 2021
0
9
A single dose of mRNA-1345 vaccine is safe and results in lower incidence of respiratory syncytial virus (RSV)-associated disease in older patients, according to a study published in the Dec. 14 issue of the New England Journal ...
Dec 14, 2023
0
2
A new research perspective titled "Targeting GITR in cancer immunotherapy—there is no perfect knowledge" has been published in Oncotarget.
Jun 21, 2023
0
12
Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" ...
Sep 10, 2012
0
0
As countries around the world race to increase COVID-19 vaccination rates within their populations, there are reports of fully immunized individuals experiencing breakthrough infections, particularly in the US and UK. A breakthrough ...
Aug 24, 2021
0
151
Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies and can ...
May 23, 2013
0
0
A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal ...
Feb 8, 2021
0
8
For healthy adults, the bivalent prefusion F respiratory syncytial virus (RSVpreF) vaccine is effective against symptomatic RSV infection and viral shedding, according to a study published in the June 23 issue of the New ...
Jun 23, 2022
0
17